Cieślak Jacek, Ausín Cristina, Grajkowski Andrzej, Beaucage Serge L
Food and Drug Administration, Bethesda, Maryland, USA.
Curr Protoc Nucleic Acid Chem. 2012 Sep;Chapter 4:Unit4.52. doi: 10.1002/0471142700.nc0452s50.
The conversion of 3',5'-disilylated 2'-O-(methylthiomethyl)ribonucleosides to 2'-O-(phthalimidooxymethyl)ribonucleosides is achieved in yields of 66% to 94%. Desilylation and dephtalimidation of these ribonucleosides by treatment with NH(4)F in MeOH produce 2'-O-aminooxymethylated ribonucleosides, which are efficient in producing stable and yet reversible 2'-conjugates upon reaction with 1-pyrenecarboxaldehyde. Exposure of 2'-pyrenylated ribonucleosides to 0.5 M tetra-n-butylammonium fluoride (TBAF) in THF or DMSO results in the cleavage of their iminoether functions to give the native ribonucleosides along with an innocuous nitrile side product. Conversely, the reaction of 2'-O-(aminooxymethyl)uridine with 5-cholesten-3-one leads to a permanent uridine 2'-conjugate, which is left unreacted when treated with TBAF. The versatility and uniqueness of 2'-O-(aminooxymethyl)ribonucleosides is demonstrated by the single or double incorporation of a reversible pyrenylated uridine 2'-conjugate into an RNA sequence. Furthermore, the conjugation of 2'-O-(aminooxymethyl)ribonucleosides with various aldehydes, including those generated from their acetals, is also presented. The preparation of 5'-O-(aminooxymethyl)thymidine is also achieved, albeit in modest yields, from the conversion of 5'-O-methylthiomethyl-3'-O-(levulinyl)thymidine to 5'-O-phthalimidooxymethyl-3'-O-(levuliny)lthymidine followed by hydrazinolysis of both 5'-phthalimido and 3'-levulinyl groups. Pyrenylation of the 5'-O-(aminooxymethyl)deoxyribonucleoside also provides a reversible 5'-conjugate that is sensitive to TBAF, thereby further demonstrating the usefulness of 5'-O-(aminooxymethyl)deoxyribonucleosides for permanent or reversible modification of DNA sequences. Curr. Protoc. Nucleic Acid Chem. 50:4.52.1-4.52.36. © 2012 by John Wiley & Sons, Inc.
3',5'-二硅基化的2'-O-(甲硫基甲基)核糖核苷转化为2'-O-(邻苯二甲酰亚胺氧基甲基)核糖核苷的产率为66%至94%。在甲醇中用NH(4)F处理这些核糖核苷进行脱硅基化和脱邻苯二甲酰亚胺化反应,生成2'-O-氨基氧基甲基化的核糖核苷,它们在与1-芘甲醛反应时能高效生成稳定且可逆的2'-缀合物。将2'-芘基化的核糖核苷暴露于四氢呋喃或二甲基亚砜中的0.5 M四正丁基氟化铵(TBAF)中,会导致其亚氨基醚官能团裂解,生成天然核糖核苷以及一种无害的腈副产物。相反,2'-O-(氨基氧基甲基)尿苷与5-胆甾烯-3-酮反应会生成一种永久性的尿苷2'-缀合物,用TBAF处理时它不会发生反应。通过将可逆的芘基化尿苷2'-缀合物单掺入或双掺入RNA序列,证明了2'-O-(氨基氧基甲基)核糖核苷的多功能性和独特性。此外,还介绍了2'-O-(氨基氧基甲基)核糖核苷与各种醛(包括由它们的缩醛生成的醛)的缀合反应。通过将5'-O-甲硫基甲基-3'-O-(乙酰基)胸苷转化为5'-O-邻苯二甲酰亚胺氧基甲基-3'-O-(乙酰基)胸苷,然后对5'-邻苯二甲酰亚胺基和3'-乙酰基进行肼解反应,也实现了5'-O-(氨基氧基甲基)胸苷的制备,尽管产率不高。5'-O-(氨基氧基甲基)脱氧核糖核苷的芘基化还提供了一种对TBAF敏感的可逆5'-缀合物,从而进一步证明了5'-O-(氨基氧基甲基)脱氧核糖核苷在DNA序列的永久性或可逆修饰中的实用性。《核酸化学实验指南》50:4.52.1 - 4.52.36。©2012约翰威立父子出版公司。